Journal ArticleDOI
Exaggerated platelet reactivity in major depression.
Dominique L. Musselman,Aaron Tomer,Amita K. Manatunga,Bettina T. Knight,Maryfrances R. Porter,Suha Kasey,Ulla M. Marzec,Laurence A. Harker,Charles B. Nemeroff +8 more
TLDR
Depressed patients exhibit enhanced baseline platelet activation and responsiveness in comparison with normal subjects, which may be a mechanism by which depression is a significant risk factor for ischemic heart and cerebrovascular disease and/or mortality after myocardial infarction.Abstract:
Objective: This study iizvestigated whether depressed patients exhibit exaggerated platelet reactivity. Method: In vivo platelet activatioiz, secretioz, and dose-response aggregation were measured in 12 depressed patients and eight normal comparison subjects after overizight bed rest aizd following orthostatic challenge. Results: The depressed patients exhibited increased platelet activation at baseli,ze, demonstrated by increased binding of monoclonal antibody (moAb) annexin V protein reacting with prothrombinase complex binding sites. Followizg orthostatic challeizge, the depressed patients exhibited increases in binding of moAbs PACI a,zd anti-LIBS1 agaiizst actii'atedglycoprotein Jib/lila and GEI2 against P-selecti,z expressed 111)01? secretion. The normal comparison subjects exhibited increases in platelet activatioz only with GE I 2. Conclusions: Depressed patients exhibit enhazced baseline platelet activation and respozsiveness in comparisoz with normal subjects. Heightened susceptibility to platelet acti- vation flltlV he a mechanism b�' which depression is a significant risk factor for ischemic heart azd cerebrovascular disease and/or mortality after myocardial infarction. (AmJ Psychiatry 1996; 153:1313-1317)read more
Citations
More filters
Journal ArticleDOI
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Diane E. Bild,David A. Bluemke,Gregory L. Burke,Robert Detrano,Ana V. Diez Roux,Aaron R. Folsom,Philip Greenland,David R. JacobsJr.,Richard A. Kronmal,Kiang Liu,Jennifer C. Nelson,Daniel H. O'Leary,Mohammed F. Saad,Steven Shea,Moyses Szklo,Russell P. Tracy +15 more
TL;DR: The Multi-Ethnic Study of Atherosclerosis was initiated in July 2000 to investigate the prevalence, correlates, and progression of subclinical cardiovascular disease (CVD) in a population-based sample of 6,500 men and women aged 45-84 years for identification and characterization of CVD events.
Journal ArticleDOI
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
TL;DR: Suggestions to improve the assessment of behavioral interventions include more complete delineation of the physiological mechanisms by which such interventions might work; increased use of new, more convenient "alternative" end points for behavioral intervention trials; development of specifically targeted behavioral interventions (based on profiling of patient factors); and evaluation of previously developed models of predicting behavioral change.
Journal ArticleDOI
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Stephan D. Fihn,Julius M. Gardin,Jonathan Abrams,Kathleen Berra,James C. Blankenship,Apostolos P. Dallas,Pamela S. Douglas,JoAnne M. Foody,Thomas C. Gerber,Alan L. Hinderliter,Spencer B. King,Paul Kligfield,Harlan M. Krumholz,Raymond Y. Kwong,Michael J. Lim,Jane A. Linderbaum,Michael J. Mack,Mark A. Munger,Richard L. Prager,Joseph F. Sabik,Leslee J. Shaw,Joanna D. Sikkema,Craig R. Smith,Sidney C. Smith,John A. Spertus,Sankey V. Williams +25 more
TL;DR: A Report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines, and the AmericanCollege of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for CardiovascularAngiography and Interventions, and Society of ThorACic Surgeons
Journal ArticleDOI
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Donna M. Fick,James W. Cooper,William E. Wade,Jennifer L. Waller,J. Ross Maclean,Mark H. Beers +5 more
TL;DR: The application of the Beers criteria and other tools for identifying potentially inappropriate medication use will continue to enable providers to plan interventions for decreasing both drug-related costs and overall costs and thus minimize drug- related problems.
Journal ArticleDOI
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.
Lisa F. Berkman,James A. Blumenthal,Matthew M. Burg,Robert M. Carney,Diane J. Catellier,Marie J. Cowan,Susan M. Czajkowski,Robert F. DeBusk,James D. Hosking,Allan S. Jaffe,Peter G. Kaufmann,Pamela H. Mitchell,James E. Norman,Lynda H. Powell,James M. Raczynski,Neil Schneiderman +15 more
TL;DR: The intervention improved depression and social isolation, although the relative improvement in the psychosocial intervention group compared with the usual care group was less than expected due to substantial improvement in usual care patients.
References
More filters
Journal ArticleDOI
Depression Following Myocardial Infarction: Impact on 6-Month Survival
TL;DR: Major depression in patients hospitalized following an MI is an independent risk factor for mortality at 6 months and its impact is at least equivalent to that of left ventricular dysfunction (Killip class) and history of previous MI.
Journal ArticleDOI
Depression and 18-month prognosis after myocardial infarction.
TL;DR: Depression while in the hospital after an MI is a significant predictor of 18-month post- MI cardiac mortality and significantly improves a risk-stratification model based on traditional post-MI risks, including previous MI, Killip class, and PVCs.
Book
Monoclonal antibodies: Principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry, and immunology
TL;DR: This work describes the construction, Screening and Expression of Recombinant Antibodies, and analysis of Antigens Recognized By Monoclonal Antibody, which are part of the cellular Basis of the Immune System and the Generation of ConventionalAntibodies.
Journal ArticleDOI
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
TL;DR: A murine monoclonal anti-platelet antibody is developed and characterized that binds to activated platelets, but not to unstimulated platelets and inhibits fibrinogen-mediated platelet aggregation.
Journal ArticleDOI
Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry
TL;DR: It is demonstrated that activated platelets can be reliably detected in whole blood using activation-dependent monoclonal antibodies and flow cytometry and may be useful to assess the degree of platelet activation and the efficacy of antiplatelet therapy in clinical disorders.